Policy Changes Proposed to Meet Projected Need for Palliative Care
Modeling suggests the number of palliative care physicians is decreasing
Young Male Adults Have Lower Cancer Burden Than Women
Incidence of all invasive cancers decreased among men aged 20 to 49 years, increased in women
Allo-HCT With Unrelated Donor Tied to Better Outcomes in AML
In active AML, outcomes superior for allo-HCT with unrelated donor than for cord blood transplantation
ASCO: Survival Up With Ribociclib in Advanced Breast Cancer
OS longer for premenopausal patients receiving ribociclib in addition to endocrine therapy
ASCO: Combo Regimen Effective in CLL With Coexisting Conditions
Progression-free survival longer with venetoclax-obinutuzumab versus chlorambucil-obinutuzumab
ASCO: Olaparib Beats Placebo for BRCA-Related Pancreatic Cancer
Progression-free survival significantly improved with olaparib versus placebo for metastatic disease
Higher Surgical Volume May Improve Outcomes in Cervical Cancer
Findings show radical hysterectomy at high-volume centers tied to better survival in early cervical cancer
ASCO: Low-Dose Chemo Benefits Advanced Gastroesophageal Cancer
Elderly, frail receiving 60 percent of oxaliplatin/capecitabine dose have noninferior PFS, less toxicity
Gout Linked to Increased Risk for Venous Thromboembolism
Venous thromboembolism risk similar for patients with gout regardless of urate-lowering therapy
ASCO: Pembrolizumab Noninferior to Chemo in Advanced Gastric Cancer
For patients with PD-L1 combined positive score of ≥10, pembrolizumab prolongs overall survival
